Open Prescription Drug Databases Explorer

Global Therapeutics Infrastructure

Open Government Prescription Drug Registries

Public health governance relies heavily on computational transparency and post-market safety surveillance. This portal unifies the technical architecture, legal frameworks, and informatics schemas across major human and animal therapeutic registries.

Overview of the Open Pharmaceutical Information Infrastructure

This section presents an executive view of the world's primary public drug databases across both human and veterinary domains. Drug registries operationalize statutory approval pathways (such as Hatch-Waxman, BPCIA, GADPRA, and AMDUCA), establish patent linkages, guide bioequivalence evaluations, and aggregate post-market safety signals. Explore the metric summary cards and distribution breakdown below to understand how regulatory authorities structure data across distinct species boundaries.

Indexed Databases

US, EU, UK, Canada

Human Registries

Orange, Purple, DailyMed...

Veterinary Registries

Green Book, VetGRAM, UPD...

Safety Ontologies

MedDRA / VeDDRA

5-Tier vs 4-Tier Hierarchies

Database Scope & Domain Coverage

Distribution of primary open repositories by specialization domain.

Source: Synthetic cataloging from FDA, NLM, USDA, EMA, UK VMD, & Health Canada.

Key Functional Divergences

Why human and animal therapeutics require fundamentally different architecture.

👤 Human Therapeutics Focus Bioequivalence (AB/AA TE ratings), individualized pharmacokinetic clearance, substitution rights at retail pharmacies, and complex biologic interchangeability (351(k)).

🐾 Veterinary Therapeutics Focus Taxonomic biodiversity across species, flock/herd aggregate dosing, operator exposure hazards, and statutory food withdrawal times (WDT) to eliminate tissue residues.

🛡️ Extra-Label Dosing (AMDUCA) Strict legal limits on off-label prescribing in food animals, including absolute statutory bans (Group I) for critical human drugs like fluoroquinolones and chloramphenicol.

⚠️

Mandatory Clinical & Safety Disclaimer Not Veterinary Medical Advice

Never substitute human prescription drugs without an explicit veterinary prescription & dosage review.

Excipient Toxicity Hazard: Many human oral suspensions, syrups, and chewables contain Xylitol (birch bark extract / wood sugar) or flavorings that cause catastrophic hypoglycemic shock and acute liver necrosis in canines. In addition, species pharmacokinetics differ markedly: animal dosages are not linearly scalable from human weights. All extra-label substitutions must comply with AMDUCA (21 CFR Part 530) under a valid Veterinarian-Client-Patient Relationship (VCPR).

🐾 Pet Medication Equivalence & Generic Search

Cross-referencing FDA CVM Green Book (NADA/ANADA) with FDA CDER Orange Book (Human Generics) and AMDUCA guidelines.

Quick Species Filter:

Search Brand Name, Active Chemical Moiety, or Indication:

🔍

Equivalence Pathway Category:

Architecture Blueprint

Your Proposed Tech Stack: Astro 7.3 + Cloudflare Workers + D1 + Manticore

Engineering feasibility analysis, schema relational join strategy, and search pipeline tradeoffs.

Monthly ETL: ~15MB Raw Data

⚡ Astro & Cloudflare Edge

Rating: 10/10. Astro with Cloudflare Pages/Workers provides sub-50ms TTFB worldwide with near-zero hosting cost. Static drug pages can be pre-rendered, falling back to edge worker endpoints for real-time dynamic queries.

🔍 Manticore Search vs Pagefind

Key Tradeoff: Manticore (BM25 + FTS) is super fast, but runs as a stateful C++ daemon (requiring a VPS like Fly.io/Hetzner). If you want 100% serverless, Pagefind (static client index) or Cloudflare Vectorize + D1 FTS5 allows pure Cloudflare deployment without running a standalone server.

🗄️ Cloudflare D1 & R2

Rating: 9.5/10. Store monthly source dumps (`greenbook.txt`, `products.txt`, DailyMed XML) in R2. Transform and load indexed relational records into D1 (SQLite). The entire FDA Green Book is only ~1,200 active applications—it easily fits in a standard D1 database!

// Proposed Cloudflare D1 Schema (SQLite Relational Model)

CREATE TABLE veterinary_drugs (
  nada_number TEXT PRIMARY KEY,          -- Pioneer NADA (<200k) or Generic ANADA (>=200k)
  trade_name TEXT NOT NULL,              -- e.g. "Rimadyl Chewable Tablets"
  active_moiety TEXT NOT NULL,           -- e.g. "Carprofen"
  target_species TEXT NOT NULL,          -- JSON Array: ["Canine"]
  dosage_form TEXT NOT NULL,             -- e.g. "Chewable Tablet, 25mg, 75mg, 100mg"
  sponsor TEXT NOT NULL,                 -- e.g. "Zoetis Inc."
  is_generic BOOLEAN DEFAULT FALSE,      -- TRUE if ANADA
  pioneer_nada TEXT,                     -- Links generic ANADA back to reference pioneer NADA
  rxcui TEXT                             -- NLM RxNorm Clinical Unique Identifier
);

CREATE TABLE human_cross_references (
  id INTEGER PRIMARY KEY AUTOINCREMENT,
  active_moiety TEXT NOT NULL,           -- Joins with veterinary_drugs.active_moiety
  human_trade_name TEXT,                 -- e.g. "Prozac", "Prilosec", "Augmentin"
  human_generic_available BOOLEAN,       -- Orange Book AB rating available
  amduca_tier TEXT,                      -- "Permitted Extra-Label", "Group I Prohibited", "Group II Restricted"
  excipient_warning TEXT,                -- e.g. "DO NOT USE LIQUID: Contains Xylitol!"
  typical_cost_differential TEXT        -- e.g. "Veterinary Brand: $85/mo vs Human Generic: $12/mo"
);

Human vs. Veterinary Regulatory Frameworks

Comparing statutory pathways, equivalence determinations, and regulatory safeguards between human clinical drug products and veterinary formulations.

Dimension	Human Prescription Databases	Veterinary Prescription Databases
Primary US Catalogs	FDA Orange Book, Drugs@FDA, FDA Purple Book	FDA CVM Green Book, Animal Drugs @ FDA
Statutory Pathways	NDA (FD&C Act § 505(b)), ANDA (§ 505(j)), BLA (PHS Act § 351)	NADA (FD&C Act § 512(b)), ANADA (§ 512(c)), CNADA (§ 571 MUMS)
Equivalence Standards	Therapeutic Equivalence (TE) codes (e.g., AB, AA, B) based on bioequivalence	Bioequivalence matching pioneer NADA; no explicit TE codes assigned
Biologics & Biosimilars	Purple Book: 351(k) Biosimilar vs. Interchangeable (12-yr exclusivity)	FDA CVM (therapeutics) or USDA APHIS (immunobiologics/vaccines)
Post-Market Surveillance	FAERS via openFDA (`/drug/event.json`)	CVM ADE via openFDA (`/animalandveterinary/event.json`)
Controlled Ontology	MedDRA (5-level ICH hierarchy)	VeDDRA (4-level VICH hierarchy)
Unit of Observation	Individual patient encounter	Individual animal, aggregate herd, flock, or aquaculture pen
Food Safety & Residues	Not applicable (focus on personal ADME & individual safety)	Mandatory Withdrawal Times (WDT), WDIs, and tissue tolerance limits
Extra-Label Prescribing	Prescriber discretion guided by medical standard-of-care	Restricted under AMDUCA (21 CFR Part 530); absolute Group I bans; VCPR required
Semantic Labeling	DailyMed (SPL XML), RxNorm concept graph (RxCUI)	Blue Bird Feeds, Animal Drugs @ FDA FOI, DailyMed vet subset

Hatch-Waxman Act (1984)

FDA Orange Book Architecture

Links generic approval under ANDAs (§ 505(j)) with pioneer NDA patent protections. Uses two-letter Therapeutic Equivalence (TE) codes:

"A" Ratings: Bioequivalent with no unresolved in vivo issues (e.g., AB, AA, AN, AP, AT). Eligible for substitution.
"B" Ratings: Bioequivalence NOT established due to active ingredient or delivery variations. Ineligible for automatic substitution.

GADPRA (1988) & MUMS Act (2004)

FDA Green Book Architecture

Established generic animal drug pathways (ANADA) and minor species provisions. Key numbering conventions:

NADA (< 200-000): Pioneer animal drug approvals based on clinical safety, efficacy, and food safety.
ANADA (≥ 200-000): Generic animal drug applications demonstrating bioequivalence.
CNADA (MUMS): Conditional approval for minor species or rare conditions based on reasonable expectation of effectiveness.

Post-Market Pharmacovigilance & Medical Ontologies

Post-market surveillance tracks spontaneous adverse event reports to calculate disproportionality metrics (PRR/ROR). Human safety relies on MedDRA, while veterinary safety uses VeDDRA.

Hierarchical Depth Comparison

Structural levels between human MedDRA and veterinary VeDDRA vocabularies.

MedDRA employs 5 tiers; VeDDRA employs 4 tiers under VICH standards.

Ontology Structural Mapping

How clinical symptoms roll up from raw observations to systemic categories.

MedDRA (Human ICH Hierarchy)

1. System Organ Class (SOC): Broad physiological grouping (e.g., Cardiac disorders).

2. High-Level Group Term (HLGT): Structural pathophysiological category.

3. High-Level Term (HLT): Related symptom cluster.

4. Preferred Term (PT): Primary operational unit for PRR/ROR calculation.

5. Lowest-Level Term (LLT): Highly specific clinical text string.

VeDDRA (Veterinary VICH Hierarchy)

1. System Organ Class (SOC): Anatomical/systemic grouping.

2. High-Level Term (HLT): Functional pathophysiological group.

3. Preferred Term (PT): Standardized reporting term (e.g., Ataxia, LOEE).

4. Low-Level Term (LLT): Field symptom entries and colloquial codes.

Unique Variables in Veterinary Pharmacovigilance

📊

Herd & Flock Impact Numbers

Veterinary treatments are often delivered via water or feed to thousands of animals simultaneously. Reports capture aggregate count treated, showing clinical signs, and herd mortality.

⚠️

Lack of Expected Efficacy (LOEE)

LOEE serves as a critical primary safety endpoint, providing early public detection of anthelmintic resistance or agricultural antimicrobial failures across production systems.

🩺

Human Operator Exposure

Veterinary event logs track accidental human needle-stick injuries, cutaneous splash exposure, or topical toxicity occurring during the administration of animal pharmaceuticals.

AMDUCA Extra-Label Drug Use & Food Safety

The Animal Medicinal Drug Use Clarification Act of 1994 (AMDUCA; 21 CFR Part 530) governs off-label drug use in animals. The USDA-funded FARAD (VetGRAM) repository establishes statutory Withdrawal Times (WDT) to protect the human food supply from chemical residues.

Classification	Drug Classes / Specific Agents	Public Health Rationale & Statutory Restrictions
Group I Ban	Chloramphenicol	Complete prohibition in food animals due to idiosyncratic, non-threshold human aplastic anemia.
Group I Ban	Clenbuterol	Prohibited in all food animals due to severe human cardiotoxicity and tachyarrhythmias from meat residues.
Group I Ban	Diethylstilbestrol (DES)	Absolute prohibition due to documented human carcinogenicity and teratogenicity.
Group I Ban	Fluoroquinolones	Prohibited from extra-label use in food animals to preserve critical human therapeutics against resistant pathogens.
Group I Ban	Glycopeptides (e.g., Vancomycin)	Absolute prohibition in food-producing species to prevent vancomycin-resistant enterococci (VRE) selection.
Group I Ban	Nitroimidazoles & Nitrofurans	Prohibited in all food-producing species due to mutagenic and carcinogenic properties (e.g., Metronidazole).
Group II Restricted	Cephalosporins (excl. cephapirin)	Prohibited for disease prevention, off-label doses, routes, or unapproved species in cattle, swine, chickens, and turkeys.
Group II Restricted	Sulfonamides	Prohibited in adult lactating dairy cattle due to persistent, violative milk residues and human hypersensitivity risks.
Group II Restricted	Phenylbutazone	Prohibited in female dairy cattle 20 months or older due to severe bone marrow toxicity and blood dyscrasias in humans.
Group II Restricted	Adamantanes & Neuraminidase Inhibitors	Prohibited in all poultry species (chickens, turkeys, ducks) to mitigate resistance selection against pandemic influenza drugs.

Veterinarian-Client-Patient Relationship (VCPR)

Under AMDUCA, Extra-Label Drug Use (ELDU) is strictly illegal unless conducted within a valid VCPR. The prescribing veterinarian assumes responsibility for clinical judgment, ensures adequate animal identification, and specifies extended Withdrawal Intervals (WDI) based on pharmacokinetic modeling.

USDA FARAD VetGRAM Architecture

The Food Animal Residue Avoidance Databank maintains VetGRAM. FARAD pharmacologists calculate scientifically validated tissue depletion curves and Maximum Residue Limits (MRLs) for off-label regimens, protecting meat, milk, and egg safety.

Technical Informatics, Database Schemas & ETL

Engineering considerations for ingesting, transforming, and linking public drug datasets. Includes relational join structures, parsing rules, and normalized semantic graph mapping.

RxNorm Semantic Hierarchy Architecture

Navigating NLM's clinical drug concept graph via RxCUI identifiers.

1. Ingredient (IN)

Metformin

Active Chemical Moiety

2. Drug Form (CDF)

Metformin Oral Tablet

Moiety + Route / Form

3. Clinical Drug (SCD)

Metformin HCl 500MG Oral Tablet

Ingredient + Strength + Form

4. Branded Drug (SBD)

Glucophage 500MG Oral Tablet

Proprietary Brand Entity

Dataset File Specifications & Access Protocols

Repository	Format	Delimiter / Syntax	Primary Linkage Keys	Update Cadence
FDA Orange Book	Flat ASCII Text	`~` (Tilde)	Composite: `Appl_No` (6-digit) + `Product_No` (3-digit)	Monthly
Drugs@FDA	Relational Flat Text	`\t` (Tab)	`ApplNo` + `SubmissionType` + `SubmissionNo`	Daily (Mon-Fri)
FDA Purple Book	CSV / XLSX Reports	Comma-separated	Biologics License Application (`BLA`) Number	Monthly
NLM DailyMed	ZIP Archives / REST	HL7 SPL XML	GUID Set ID, Global Unique Identifier, NDC mapping	Daily / Monthly
Health Canada DPD	Text Extracts / REST	Tab & Comma	8-digit Drug Identification Number (`DIN`) & `drug_code`	Regular Releases
openFDA (FAERS & Vet)	Partitioned JSON / REST	Structured JSON	`safetyreportid`; MedDRA PT / VeDDRA PT codes	Quarterly

ETL Pipeline Consideration Spotlight Data Ingestion Rules

# 1. Orange Book Tilde Parsing & Key Padding:

Orange Book uses ~ delimiters to avoid split errors on chemical commas. When linking products.txt with patent.txt, pad Appl_No with leading zeros to 6 digits and Product_No to 3 digits.

# 2. openFDA Veterinary JSON Schema Arrays:

Unlike human FAERS JSON records (single patient object), veterinary payloads in /animalandveterinary/event.json contain an animal object representing aggregate herd counts, and nested reaction arrays containing VeDDRA Low-Level Terms requiring rollup to Preferred Terms.

✨ Powered by Cloudflare Workers AI · GLM-5.3 Flash & Deepgram Aura-2 Speech

Therapeutics AI Regulatory Intelligence Co-Pilot

Interactively query cross-species drug safety laws, map clinical symptoms to MedDRA or VeDDRA ontologies, generate openFDA API queries, and listen to synthesized audio briefings.

Model: @cf/zai-org/glm-5.3-flash

Regulatory Analysis Query

Standard

Enter regulatory, drug name, or clinical question:

Web Search Grounding (unavailable on Workers AI)

Answers come from the model's training knowledge only — no live citations. Verify regulatory specifics against FDA & EMA publications.

Pre-Engineered Scenarios

Intelligence Synthesis Terminal Ready

✨

Select a pre-engineered scenario or enter your inquiry

GLM-5.3 Flash will analyze statutory drug frameworks (FDA Orange/Green/Purple Books, AMDUCA 21 CFR 530, FARAD, VICH VeDDRA, and openFDA datasets).

Open PharmDB Portal